MAP4K1 antibody (AA 231-330) (Cy5)
Quick Overview for MAP4K1 antibody (AA 231-330) (Cy5) (ABIN754337)
Target
See all MAP4K1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 231-330
-
Cross-Reactivity
- Human
-
Predicted Reactivity
- Mouse,Rat,Cow
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human MAP4K1
-
Isotype
- IgG
-
-
-
-
Application Notes
-
FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- MAP4K1 (Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 (MAP4K1))
-
Alternative Name
- MAP4K1
-
Background
-
Synonyms: Hematopoietic progenitor kinase 1, Hematopoietic progenitor kinase, HPK1, Human Hematopoietic Progenitor Kinase, M4K1_HUMAN, Map4k1, MAPK/ERK kinase kinase kinase 1, MEK kinase kinase 1, MEKKK 1, Mitogen Activated Protein Kinase Kinase Kinase Kinase 1, Mitogen-activated protein kinase kinase kinase kinase 1.
Background: May play a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway. May play a role in hematopoietic lineage decisions and growth regulation.
-
Gene ID
- 11184
-
Pathways
- TCR Signaling, Signaling of Hepatocyte Growth Factor Receptor
Target
-